Bausch Health Companies Inc (BHC) Stock Price, Quote & News

Company Profile

Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company, develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, generic pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health in the United States and internationally. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segm...

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: 514 744 6792

Website: www.bauschhealth.com

Address:

2150 St. ElzEar Boulevard West, Laval, Canada

FHMaitland Dec. 24 at 4:26 AM

$BHC Buy mid-6's. Sell mid-7's. Repeat. Keep a few shares each time you sell, as eventually the company will pay off its debt and break out. I've executed this strategy five times just this year. Basically free money. Merry Christmas to all!

0 · Reply

Doozio Dec. 23 at 10:01 PM

$BHC out of the tightness Roger starts rocking it was always ENTA 🐒🍌🧠⏰♾️

0 · Reply

btradingwarehouse Dec. 23 at 6:18 PM

$BHC ...2BULLS... ... Wish you all Merry Christmas Hanukkah and Kwanzaa happy New Year Do not forget to smile We good Peace Love Money Smile ... ... Allow me the very last bs for this year: If you are in deep shit as I am---do NOT sell one single share If you are about to start position (long)---do NOT do that yet If you want to trade this beauty--you are on your own ...

0 · Reply

FU2 Dec. 22 at 4:28 PM

$BHC hi volume Wack-A-Mole game today.

0 · Reply

Bobberty Dec. 22 at 2:47 PM

$BHC what an odd 1 year chart. $7 is almost an anchor for the entire year.

1 · Reply

brunoq14 Dec. 22 at 12:31 PM

$BHC According to AI, the Phase 3 trial for larsucosterol, the breakthrough status drug for alcohol related hepatitis acquired in the Durect purchase, is expected to begin very soon.

0 · Reply

greyfox Dec. 19 at 5:51 PM

$BHC dumb question re fuckery. When a stock is fuckery'd around then its logical that fuckery will continue unabated!

3 · Reply

greyfox Dec. 19 at 4:13 PM

$BHC wow...finally back over $7. will it hold or will fuckery come back onto the equation??

1 · Reply

greyfox Dec. 19 at 3:06 PM

$BHC this board is boring and dead. Anyone out there reading this BS?

2 · Reply

greyfox Dec. 19 at 3:02 PM

$BHC will they push this to throw a bone to the $7 calls expiring today? Probably not as that would involve fuckery on our behalf! One day this dog will rise and hope it doesnt have a stroke from the stress of rising or else someone will take it out for super cheap?

0 · Reply

Bausch Health Announces Final Results and Expiration of Exchange Offers

Dec 8, 2025, 7:22 PM EST - 20 days ago

Bausch Health Announces Early Exchange Offer Results for Exchange Offers

Dec 2, 2025, 12:43 PM EST - 26 days ago

Bausch Health Companies Inc. (BHC) Presents at Evercore 8th Annual Healthcare Conference Transcript

Dec 1, 2025, 7:00 AM EST - 27 days ago

Bausch Health's Aesthetics Business, Solta Medical, Acquires Longtime Distribution Partner, the Shibo Group, to Strengthen Presence in China

Nov 24, 2025, 7:05 AM EST - 4 weeks ago

Bausch Health Announces Launch of Offers to Exchange Certain Existing Senior Secured Notes

Nov 18, 2025, 7:00 AM EST - 5 weeks ago

Bausch Health to Participate in the 8th Annual Evercore Healthcare Conference

Nov 13, 2025, 8:18 AM EST - 6 weeks ago

Bausch + Lomb CEO Brent Saunders on growth outlook: Biggest contributor will be in surgical

Nov 13, 2025, 7:00 AM EST - 6 weeks ago

Bausch + Lomb to Highlight Company Transformation and Growth Strategy at Investor Day

Nov 11, 2025, 7:07 AM EST - 6 weeks ago

Bausch Health: Solid Q3 Performance Reinforces Deleveraging Path

Nov 5, 2025, 8:00 AM EST - 7 weeks ago

Bausch Health's OraPharma Expands into Canada and Puerto Rico, Helping to Address Unmet Needs in Periodontal Disease

Nov 3, 2025, 4:30 PM EST - 7 weeks ago

Bausch + Lomb to Hold Investor Day on Nov. 13

Oct 31, 2025, 7:45 AM EDT - 2 months ago

Why Bausch Health Is A Buy After Rising 10% On Third-Quarter Results

Oct 29, 2025, 8:26 PM EDT - 2 months ago

Bausch Health Companies Inc. (BHC) Q3 2025 Earnings Call Transcript

Oct 29, 2025, 4:05 PM EDT - 2 months ago

Bausch Health Announces Third Quarter 2025 Results

Oct 20, 2025, 10:57 AM EDT - 2 months ago

Activist Investor Seeks Strategic Overhaul At Contact Lens Maker Cooper, Suggests Merger With Bausch + Lomb

Oct 9, 2025, 7:00 AM EDT - 2 months ago

Bausch Health Announces Results of Special Meeting of Shareholders

Sep 30, 2025, 8:00 AM EDT - 3 months ago

Bausch Health's Aesthetic Business, Solta Medical, Brings Non-Invasive Aesthetic Innovations to National TV

Sep 30, 2025, 7:00 AM EDT - 3 months ago

Bausch Health to Announce Third Quarter 2025 Results on October 29

Sep 29, 2025, 8:00 AM EDT - 3 months ago

Bausch Health's OraPharma Introduces "OraTalks," a New Podcast Bringing Bold Conversations to Dentistry

Sep 11, 2025, 12:04 PM EDT - 3 months ago

Bausch Health: Repricing Continues As Deleveraging Gains Traction

Sep 11, 2025, 8:35 AM EDT - 3 months ago

Bausch Health Completes Acquisition of DURECT Corporation, Expanding Late-stage Liver Disease Portfolio

Sep 11, 2025, 7:00 AM EDT - 3 months ago

Bausch + Lomb Announces Publication of enVista Envy™ Full Range of Vision Intraocular Lens Pivotal U.S. Clinical Trial

Sep 9, 2025, 7:00 AM EDT - 3 months ago

Bausch + Lomb Announces Publication of Data From a Prospective Study Evaluating the Efficacy of XIIDRA® in Alleviating Discomfort in Symptomatic Contact Lens Wearers

Sep 5, 2025, 8:02 AM EDT - 4 months ago

Bausch Health's Aesthetic Business, Solta Medical, Surpasses Milestone of 5 Million Skin Tightening Treatments with Thermage(R) Non-Surgical System

Aug 26, 2025, 8:00 AM EDT - 4 months ago

Bausch Health Announces Extension of DURECT Corporation Tender Offer to September 10, 2025

DRRX

Aug 21, 2025, 8:02 AM EDT - 4 months ago

Bausch Health, Canada Inc. Treatment for Acne Vulgaris, (Pr)CABTREO(TM) (Clindamycin Phosphate, Adapalene and Benzoyl Peroxide Gel), Now Available Through Public Drug Plans of Quebec and Saskatchewan

Aug 18, 2025, 5:48 PM EDT - 4 months ago

Bausch + Lomb board members resign after Icahn agreement ends

Aug 15, 2025, 2:30 PM EDT - 4 months ago

Bausch Health Announces Increase in Shareholding by its Chairperson of the Board and Board Changes

Aug 12, 2025, 1:02 PM EDT - 4 months ago

Why Bausch Health Stock Surged By Nearly 20%

Aug 7, 2025, 8:00 AM EDT - 5 months ago

Bausch Health Announces 2025 Gastrointestinal Health Scholars Program Winners

Jul 30, 2025, 11:30 PM EDT - 5 months ago

Bausch Health Companies Inc. (BHC) Q2 2025 Earnings Call Transcript

Jul 30, 2025, 4:05 PM EDT - 5 months ago

Bausch Health Announces Second Quarter 2025 Results

Jul 29, 2025, 2:21 PM EDT - 5 months ago

Bausch Health Adds Late-Stage Ready Alcohol Liver Disease Drug Candidate In $63 Million DURECT Buyout

DRRX

Jul 29, 2025, 7:00 AM EDT - 5 months ago

Bausch Health to Acquire DURECT Corporation, Strengthening Commitment to Developing Innovative Solutions for Patients with Liver Disease

DRRX

Jul 29, 2025, 7:00 AM EDT - 5 months ago

Bausch + Lomb Announces Publication of Phase 3 Data on LUMIFY® Preservative Free Redness Reliever Eye Drops

Jul 28, 2025, 9:10 AM EDT - 5 months ago

Bausch Health to Reduce Debt by Approximately $900 Million Using Cash On Hand

Jul 24, 2025, 8:02 AM EDT - 5 months ago

Bausch Health Announces the Appointment of Two New Members to Its Board of Directors

Jul 10, 2025, 5:00 PM EDT - 6 months ago

CORRECTING and REPLACING: Bausch Health, Canada Inc. Treatment for Acne Vulgaris, (Pr)CABTREO(TM) (clindamycin phosphate, adapalene and benzoyl peroxide gel), Now Available Through Public Drug Plans of Ontario, Nova Scotia and Two Federal Programs

Jul 10, 2025, 4:15 PM EDT - 6 months ago

Bausch Health Appoints New Chief Accounting Officer

Jul 9, 2025, 8:00 AM EDT - 6 months ago

Bausch Health, Canada Inc. Treatment for Acne Vulgaris, (Pr)CABTREO(TM) (clindamycin phosphate, adapalene and benzoyl peroxide gel), Now Available Through Public Drug Plans of Ontario, Quebec and Two Federal Programs

Jul 7, 2025, 8:00 AM EDT - 6 months ago

Bausch Health's Gastroenterology Business, Salix Pharmaceuticals, Launches Fresh "I Wish I Knew" Campaign to Educate People About Xifaxan(R) (rifaximin) for Adults at Risk of Overt Hepatic Encephalopathy Recurrence

Jul 2, 2025, 7:00 AM EDT - 6 months ago

Bausch Health to Announce Second Quarter 2025 Results on July 30

Jun 26, 2025, 4:30 PM EDT - 6 months ago

Bausch + Lomb Announces Closing of Upsized €675 Million Senior Secured Notes Offering and Partial Credit Agreement Refinancing, Including Upsized $2.325 Billion Term Loan Facility

Jun 22, 2025, 5:00 AM EDT - 6 months ago

A Billionaire Trump Supporter Is Buying These Two Stocks

PPTA

Jun 18, 2025, 11:01 AM EDT - 6 months ago

Bausch Health Shares Rise as Nonexecutive Chairperson Paulson Buys $21.2M in Shares

Jun 16, 2025, 4:04 AM EDT - 6 months ago

Repricing Potential Driven By Deleveraging

Jun 4, 2025, 6:59 AM EDT - 7 months ago

Bausch + Lomb Launches Blink® Nourish Lubricating Eye Drops and Blink Boost Lubricating Eye Drops in the United States

May 21, 2025, 9:45 AM EDT - 7 months ago

Facial Injectable Market Forecasts Report 2025-2030, Competitive Analysis of Key Players - Allergan, Bausch Health, Bloomage Biotechnology, and Galderma

May 21, 2025, 6:59 AM EDT - 7 months ago

Bausch + Lomb Launches New LUMIFY® Preservative Free Redness Reliever Eye Drops in the United States

May 14, 2025, 4:15 PM EDT - 8 months ago

Bausch Health Announces 2025 Annual Meeting of Shareholder Results

FHMaitland Dec. 24 at 4:26 AM

0 · Reply

Doozio Dec. 23 at 10:01 PM

$BHC out of the tightness Roger starts rocking it was always ENTA 🐒🍌🧠⏰♾️

0 · Reply

btradingwarehouse Dec. 23 at 6:18 PM

0 · Reply

FU2 Dec. 22 at 4:28 PM

$BHC hi volume Wack-A-Mole game today.

0 · Reply

Bobberty Dec. 22 at 2:47 PM

$BHC what an odd 1 year chart. $7 is almost an anchor for the entire year.

1 · Reply

brunoq14 Dec. 22 at 12:31 PM

$BHC According to AI, the Phase 3 trial for larsucosterol, the breakthrough status drug for alcohol related hepatitis acquired in the Durect purchase, is expected to begin very soon.

0 · Reply

greyfox Dec. 19 at 5:51 PM

$BHC dumb question re fuckery. When a stock is fuckery'd around then its logical that fuckery will continue unabated!

3 · Reply

greyfox Dec. 19 at 4:13 PM

$BHC wow...finally back over $7. will it hold or will fuckery come back onto the equation??

1 · Reply

greyfox Dec. 19 at 3:06 PM

$BHC this board is boring and dead. Anyone out there reading this BS?

2 · Reply

greyfox Dec. 19 at 3:02 PM

0 · Reply

marti837 Dec. 19 at 2:54 PM

$BHC Will Paulson pull a rabbit out of a hat?

1 · Reply

greyfox Dec. 18 at 8:47 PM

$BHC well, they got me leaning forward on an armless chair and so I have assumed the position. Just waiting for the next step.... fuckery I say, nothing but fuckery! Dont touch my belt!!

0 · Reply

Valmaro Dec. 18 at 4:46 PM

$BHC sometimes it takes a while till all Chess pieces are placed on the right position…

1 · Reply

greyfox Dec. 18 at 2:10 PM

$BHC more fuckery in store for today? When will this nonsense stop or people go behind bars??

0 · Reply

FU2 Dec. 17 at 9:01 PM

$BHC POS, don't buy till $6.25.

0 · Reply

kellysmith1 Dec. 17 at 5:16 PM

$BHC entire market tanked

0 · Reply

greyfox Dec. 17 at 2:40 PM

$BHC more fuckery going on. When will this stop?? No reason for this to be at these levels other than suppression and manipulation!! May the board get lumps of coal in their stockings!

0 · Reply

Broview Dec. 16 at 6:28 PM

$BHC earnings great! Please lower the debt?

0 · Reply

macd87 Dec. 16 at 2:57 PM

$BHC I think it's going to spike real soon

1 · Reply

Broview Dec. 16 at 12:58 AM

$BHC double bags?

0 · Reply

greyfox Dec. 15 at 7:58 PM

$BHC time to get off hands and start buying. Great stocking stuffers for Christmas.

0 · Reply

greyfox Dec. 15 at 7:57 PM

$BHC keeps; accumulating and buying...not doing it for our good health. So is takeover in the works?? If so, this is a steal at this price. Lets buy and hold and make them pay fair value for this juggernaut of a company. Okay naysayers, say I am wrong!!

0 · Reply

Market Cap	2.67B
Revenue (ttm)	9.63B
Net Income (ttm)	-46.00M
EPS (ttm)	N/A
PE Ratio	1.89
Forward PE	1.86
Profit Margin	-0.48%
Debt to Equity Ratio	59.11

Volume	1,016,800
Avg Vol	2,746,516
Day's Range	N/A - N/A
Shares Out	370.86M
Stochastic %K	77%
Beta	0.41
Analysts	Hold
Price Target	$7.29